ecdysone has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Camelo, S; Dilda, PJ; Lafont, R; Latil, M; Veillet, S | 1 |
1 review(s) available for ecdysone and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Commelinaceae; COVID-19; COVID-19 Drug Treatment; Drug Development; Ecdysone; Host-Pathogen Interactions; Humans; Plant Extracts; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; SARS-CoV-2 | 2021 |